CFDE Data Portal | Search CLPTM1

	Label	Description
	CLPTM1 Gene (Entity type)	ENSG00000104853 - CLPTM1 regulator of GABA type A receptor forward trafficking
	CLPTM1 associations Collection (Entity type)	Associations for CLPTM1_associations
	CLPTM1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CLPTM1L Gene (Entity type)	ENSG00000049656 - CLPTM1 like
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135350 2 V 4 DEXAMETHASONE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE242555 1 V 0 NICOTINAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 5 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 6 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS

CLPTM1

ENSG00000104853 - CLPTM1 regulator of GABA type A receptor forward trafficking

CLPTM1 associations

Associations for CLPTM1_associations

CLPTM1 associations.tsv

A file from IDG as part of the Harmonizome project

CLPTM1L

ENSG00000049656 - CLPTM1 like

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE135350 2 V 4 DEXAMETHASONE HUMAN DN

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 2 v 0 human up

A Gene Set from LINCS

GSE242555 1 V 0 NICOTINAMIDE HUMAN DN

A Gene Set from LINCS

GSE172016 2 V 5 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 6 v 11 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.